AstraZeneca Is Acquiring CinCor Pharma: Market Values Interesting CVR At $3.21

Medical Science Laboratory: Portrait of Beautiful Black Scientist Looking Under Microscope Does Analysis of Test Sample. Ambitious Young Biotechnology Specialist, working with Advanced Equipment


CinCor Pharma (NASDAQ:CINC) is being tendered for $26 per share in cash and a Contingent Value Rights (CVR) by major pharma AstraZeneca (NASDAQ:AZN). At its current market cap, CinCor Pharma sports a market cap of around $1.26

Data by YCharts

study design Cincor

Study design CinCor (Company presentation)

Baseline demographics phase 2 study

Baseline demographics phase 2 study (Company presentation)

Phase 2 study conlusions

Phase 2 study conclusions (Company presentation)